Inogen | INGN - Собственный капитал и резервы





Собственный капитал и резервы Изменить Дата
Abbott USD 52.13B 1.3B 2025-12
Accuray USD 61.87M 19.3M 2025-09
AngioDynamics USD 176.33M 2.52M 2025-09
Artivion USD 448.23M 9.54M 2025-12
AtriCure USD 491.94M 15.43M 2025-12
Baxter International USD 6.13B 1.11B 2025-12
Becton, Dickinson and Co. USD 25.28B 108M 2025-12
Boston Scientific USD 24.23B 1.58B 2025-12
Chart Industries USD 3.23B 28.2M 2025-12
Cooper Companies USD 8.36B 124.7M 2025-12
Dexcom USD 2.75B 19.9M 2025-12
Edwards Lifesciences USD 10.2B 340.3M 2025-09
Globus Medical USD 4.57B 174.42M 2025-12
Inogen USD 197.18M 2.32M 2025-09
Insulet USD 1.52B 131.1M 2025-12
Masimo USD 721.2M 88.8M 2025-12
Medtronic USD 48.99B 128M 2025-12
Orthofix International USD 450.04M 7.55M 2025-12
Philips EUR 10.58B 204M 2025-09
ResMed USD 6.32B 199.61M 2025-12
Steris USD 7.15B 145.4M 2025-12
Stryker USD 21.78B 594M 2025-09
Tandem Diabetes Care USD 155.17M 22.2M 2025-12
Teleflex USD 3.12B 697.09M 2025-12
X T L Biopharmaceuticals USD -47K 5.48M 2025-06
Zimmer Biomet Holdings USD 12.7B 68.3M 2025-12